Sign in →

Test ID BLOD0603 Breast Carcinoma-Associated Antigen, Serum

Useful For

Aiding in the management of breast cancer in patients with metastatic disease by monitoring the progression or regression of disease in response to treatment

 

Serial testing in women with prior stage II or III breast cancer who are clinically free of disease

 

May be useful for predicting early recurrence of disease in women with treated carcinoma of the breast

 

This test is not useful for screening women for or diagnosis of carcinoma of the breast.

Specimen Type

Serum


Specimen Required


Supplies: Sarstedt Aliquot Tube, 5 mL (T914)

Collection Container/Tube:

Preferred: Serum gel

Acceptable: Red top

Submission Container/Tube: Plastic vial

Specimen Volume: 0.5 mL

Collection Instructions:

1. Within 2 hours of collection, centrifuge and aliquot serum into a plastic vial. Specimens that have not been aliquoted will be canceled.

2. Send refrigerated.


Reject Due To

Gross hemolysis Reject
Gross lipemia OK

Specimen Minimum Volume

0.25 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Refrigerated (preferred) 7 days
  Frozen  90 days
  Ambient  4 days

Day(s) Performed

Monday through Friday

Report Available

Same day/1 to 3 days

Method Name

Chemiluminometric Immunoassay

Performing Laboratory

Mayo Clinic Laboratories in Rochester

CPT Code Information

86300

Sanford Laboratories - Sioux Falls/Rapid City Note:

COVERAGE LIMITATIONS: This test has limited coverage - Please submit Commercial Insurance Patient Waiver (Non-Medicare) if applicable.

Reporting Name

Breast Carcinoma Assoc Ag(CA 27.29)

Reference Values

Males

≥18 years: ≤38.0 U/mL (use not defined)

Females

≥18 years: ≤38.0 U/mL

Reference values have not been established for patients who are younger than 18 years of age.

Serum markers are not specific for malignancy, and values may vary by method.

Test Classification

This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.

Forms

If not ordering electronically, complete, print, and send 1 of the following forms with the specimen:

-General Request (T239)

-Oncology Test Request (T729)

Secondary ID

606583
Sanford Laboratories - Sioux Falls/Rapid City Additional Information:

SANFORD LABORATORY INTERFACE BUILD INFORMATION

Result Code  Result Code Description 
17105 CA 27.29